Filed: 5/15/2026ACC: 0001104659-26-062419
📋 What this filing means
FAIRMOUNT FUNDS MANAGEMENT LLC filed this quarterly 13F‑HR report disclosing 12 equity positions with a total reported market value of $1.38B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
12
Positions
$1.38B
Total AUM (reported)
48.83M
Total Shares
Allocation by class
COM$877.53M63.4%
COM NEW$506.81M36.6%
Portfolio Concentration
Top 3$650.41M47.0%
4–10$694.30M50.2%
11–25$39.63M2.9%
Top 3 weight
47.0%
Top 10 weight
97.1%
Voting Authority Distribution
Total shares with voting rights: 48.83M
Sole
Full voting authority
48.83M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole12
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings12
Rows:
DAMORA THERAPEUTICS INC
SOLEShares8.71M
TypeSH
Market value$225.67M
16.30%
Sole
8.71M
Shared
0.00
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares2.54M
TypeSH
Market value$212.92M
15.38%
Sole
2.54M
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares5.50M
TypeSH
Market value$211.83M
15.30%
Sole
5.50M
Shared
0.00
None
0.00
SPYRE THERAPEUTICS INC
SOLEShares4.02M
TypeSH
Market value$202.67M
14.64%
Sole
4.02M
Shared
0.00
None
0.00
ORUKA THERAPEUTICS INC
SOLEShares3.71M
TypeSH
Market value$181.74M
13.13%
Sole
3.71M
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares3.91M
TypeSH
Market value$76.57M
5.53%
Sole
3.91M
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares1.86M
TypeSH
Market value$72.74M
5.25%
Sole
1.86M
Shared
0.00
None
0.00
JADE BIOSCIENCES INC
SOLEShares4.55M
TypeSH
Market value$63.98M
4.62%
Sole
4.55M
Shared
0.00
None
0.00
CRESCENT BIOPHARMA INC.
SOLEShares2.75M
TypeSH
Market value$50.48M
3.65%
Sole
2.75M
Shared
0.00
None
0.00
ZENAS BIOPHARMA INC
SOLEShares2.36M
TypeSH
Market value$46.12M
3.33%
Sole
2.36M
Shared
0.00
None
0.00
APOGEE THERAPEUTICS INC
SOLEShares298.65K
TypeSH
Market value$25.14M
1.82%
Sole
298.65K
Shared
0.00
None
0.00
INHIBIKASE THERAPEUTICS INC
SOLEShares8.63M
TypeSH
Market value$14.49M
1.05%
Sole
8.63M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
DAMORA THERAPEUTICS INCSOLE | COM NEW | 8.71M | SH | $225.67M 16.30% | 8.71M | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 2.54M | SH | $212.92M 15.38% | 2.54M | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 5.50M | SH | $211.83M 15.30% | 5.50M | 0.00 | 0.00 |
SPYRE THERAPEUTICS INCSOLE | COM NEW | 4.02M | SH | $202.67M 14.64% | 4.02M | 0.00 | 0.00 |
ORUKA THERAPEUTICS INCSOLE | COM | 3.71M | SH | $181.74M 13.13% | 3.71M | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 3.91M | SH | $76.57M 5.53% | 3.91M | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 1.86M | SH | $72.74M 5.25% | 1.86M | 0.00 | 0.00 |
JADE BIOSCIENCES INCSOLE | COM NEW | 4.55M | SH | $63.98M 4.62% | 4.55M | 0.00 | 0.00 |
CRESCENT BIOPHARMA INC.SOLE | COM | 2.75M | SH | $50.48M 3.65% | 2.75M | 0.00 | 0.00 |
ZENAS BIOPHARMA INCSOLE | COM | 2.36M | SH | $46.12M 3.33% | 2.36M | 0.00 | 0.00 |
APOGEE THERAPEUTICS INCSOLE | COM | 298.65K | SH | $25.14M 1.82% | 298.65K | 0.00 | 0.00 |
INHIBIKASE THERAPEUTICS INCSOLE | COM NEW | 8.63M | SH | $14.49M 1.05% | 8.63M | 0.00 | 0.00 |